Inventor
RABUKA DAVID
US42 patents
⚠️ This page may combine multiple inventors who share the name “RABUKA DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REDWOOD BIOSCIENCE INC
19 patentsUS9181343B2Nov 10, 2015
Antibody specific for CD22 and methods of use thereof
REDWOOD BIOSCIENCE INC13 citations92
US9833515B2Dec 5, 2017
Hydrazinyl-indole compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC11 citations91
US9310374B2Apr 12, 2016
Hydrazinyl-indole compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC16 citations91
US10604483B2Mar 31, 2020
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC5 citations83
US10464894B2Nov 5, 2019
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC5 citations83
US10259871B2Apr 16, 2019
Antibody specific for CD22 and methods of use thereof
REDWOOD BIOSCIENCE INC4 citations83
US9493413B2Nov 15, 2016
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC8 citations83
US10183998B2Jan 22, 2019
Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof
REDWOOD BIOSCIENCE INC5 citations82
US9879249B2Jan 30, 2018
Aldehyde-tagged protein-based drug carriers and methods of use
REDWOOD BIOSCIENCE INC6 citations82
US11180451B2Nov 23, 2021
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC2 citations72
US10888623B2Jan 12, 2021
Hydrazinyl-indole compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC3 citations72
US10314919B2Jun 11, 2019
Hydrazinyl-indole compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC3 citations72
US11097013B2Aug 24, 2021
Anti-HER2 antibody-maytansine conjugates and methods of use thereof
REDWOOD BIOSCIENCE INC3 citations71
US12116409B2Oct 15, 2024
Antibody specific for CD22 and methods of use thereof
REDWOOD BIOSCIENCE INC0 citations62
US12215080B2Feb 4, 2025
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC0 citations61
US12076411B2Sep 3, 2024
Anti-HER2 antibody-maytansine conjugates and methods of use thereof
REDWOOD BIOSCIENCE INC0 citations61
US11426465B2Aug 30, 2022
Hydrazinyl-indole compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC0 citations61
US10124070B2Nov 13, 2018
Anti-HER2 antibody-maytansine conjugates and methods of use thereof
REDWOOD BIOSCIENCE INC1 citations50
US9579390B2Feb 28, 2017
Compounds and methods for producing a conjugate
REDWOOD BIOSCIENCE INC0 citations41
SCHERER TECHNOLOGIES LLC R P
17 patentsUS12102689B2Oct 1, 2024
Anti-CD22 antibody-maytansine conjugates and methods of use thereof
SCHERER TECHNOLOGIES LLC R P0 citations60
US12018308B2Jun 25, 2024
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P0 citations60
US11655492B2May 23, 2023
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P0 citations60
US11053529B2Jul 6, 2021
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P0 citations60
US9951367B2Apr 24, 2018
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P1 citations60
US12296021B2May 13, 2025
Antibody conjugates and methods of making and using the same
SCHERER TECHNOLOGIES LLC R P0 citations59
US11788066B2Oct 17, 2023
Antibody conjugates and methods of making and using the same
SCHERER TECHNOLOGIES LLC R P0 citations59
US11466096B2Oct 11, 2022
Antibody conjugates and methods of making and using the same
SCHERER TECHNOLOGIES LLC R P0 citations59
US11208632B2Dec 28, 2021
Antibody conjugates and methods of making and using the same
SCHERER TECHNOLOGIES LLC R P0 citations59
US11376334B2Jul 5, 2022
Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
SCHERER TECHNOLOGIES LLC R P1 citations58
US11970546B2Apr 30, 2024
Antibody specific for Mucin-1 and methods of use thereof
SCHERER TECHNOLOGIES LLC R P0 citations57
US11980668B2May 14, 2024
Sulfatase-cleavable linkers for antibody-drug conjugates
SCHERER TECHNOLOGIES LLC R P0 citations50
US11857637B2Jan 2, 2024
Anti-CD25 antibody-maytansine conjugates and methods of use thereof
SCHERER TECHNOLOGIES LLC R P0 citations50
US10683527B2Jun 16, 2020
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P0 citations50
US10344311B2Jul 9, 2019
Activated formylglycine-generating enzymes and methods of producing and using the same
SCHERER TECHNOLOGIES LLC R P0 citations50
US10758628B2Sep 1, 2020
Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
SCHERER TECHNOLOGIES LLC R P0 citations48
US10195283B2Feb 5, 2019
Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
SCHERER TECHNOLOGIES LLC R P0 citations48